Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Josiane Delorme"'
Autor:
Nathalie, Cheron, Muriel, Riou, Ines, Babouche, Nathalie, Chevallier, Marie-Pierre, Aimee Dann, Josiane, Delorme, Virginie, Denis, Isabelle, Girard, Sandrine, Godin, Laure, Tardieu, Ibrahim, Yakoub-Agha
Publikováno v:
Bulletin du cancer. 108(12S)
Patients undergoing an allogeneic hematopoietic cell transplant (allo-HCT) need to understand and adhere to the transplant process as well as post-transplant follow-up requirements. A working group has met during the eleventh edition of the Francopho
Autor:
Ibrahim Yakoub-Agha, Anne Wallart Brejaud, Isabelle Fournier, Christelle Andrianne, Corinne Courbon, Josiane Delorme, Sarah Bole, Clotilde Aubrun, Maxime Berquier, Damien Lacroix, Ghislaine François, David Beauvais, Marlene Vercasson, Marie-France Jaivenois, Isabelle Mussot, Alexis Caulier, Laetitia Le Bars
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
Bulletin du Cancer, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
Bulletin du Cancer, John Libbey Eurotext, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
Bulletin du Cancer, 2020, 107, pp.S170-S177. ⟨10.1016/j.bulcan.2020.05.014⟩
International audience; In Europe, two CAR T-cell products, tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™), were approved in 2018. While these treatments are available for use, allogeneic hematopoietic stem cell transplantati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03db488bc89c986082e1ae6c920d6813
https://hal.archives-ouvertes.fr/hal-03492618
https://hal.archives-ouvertes.fr/hal-03492618
Autor:
Cécile Pochon, Anne Sirvent, Josiane Delorme, Jean-Hugues Dalle, Sophie Pertuisel, Charlotte Jubert, Audrey Grain, Sandrine Godin, Ibrahim Yakoub-Agha, Laure Tardieu
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (1), pp.S62-S67. ⟨10.1016/j.bulcan.2019.03.006⟩
Bulletin du Cancer, John Libbey Eurotext, 2020, 107 (1), pp.S62-S67. ⟨10.1016/j.bulcan.2019.03.006⟩
Recommendations for visits or environment restrictions, and sometimes for food are usually well described for inpatient within HSCT unit procedures where those measures are less precise and detailed for outpatient from the discharge to the immune rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9683d4bc8bee378cdf45e156154ee6c2
https://hal.archives-ouvertes.fr/hal-02979541
https://hal.archives-ouvertes.fr/hal-02979541
Autor:
David, Beauvais, Christelle, Andrianne, Clotilde, Aubrun, Maxime, Berquier, Sarah, Bole, Alexis, Caulier, Corinne, Courbon, Josiane, Delorme, Isabelle, Fournier, Ghislaine, François, Marie-France, Jaivenois, Laëtitia, Le Bars, Isabelle, Mussot, Marlène, Vercasson, Anne, Wallart Brejaud, Ibrahim, Yakoub-Agha, Damien, Lacroix
Publikováno v:
Bulletin du cancer. 107(12S)
In Europe, two CAR T-cell products, tisagenlecleucel (Kymriah™) and axicabtagene ciloleucel (Yescarta™), were approved in 2018. While these treatments are available for use, allogeneic hematopoietic stem cell transplantation centers still need to
Autor:
Anne, Sirvent, Josiane, Delorme, Sandrine, Godin, Audrey, Grain, Charlotte, Jubert, Sophie, Pertuisel, Cécile, Pochon, Laure, Tardieu, Ibrahim, Yakoub-Agha, Jean-Hugues, Dalle
Publikováno v:
Bulletin du cancer. 107(1S)
Recommendations for visits or environment restrictions, and sometimes for food are usually well described for inpatient within HSCT unit procedures where those measures are less precise and detailed for outpatient from the discharge to the immune rec